| Study Details | To assess the safety and tolerability of single escalating doses of CAN106 |
| Protocol Number | CAN106 |
| Phase | I |
| Therapeutic Area | Haematology |
| Subject Types | Healthy |
| Indication | PNH |
| Principal Investigator | Dr Khoo Chin Meng |
| Investigator Product / Device | CAN106 |
| Sponsor | CARE Pharma Shanghai Ltd |
